BUZZ-GenScript jumps on associate's cancer drug's $334 mln sales

Reuters
01-23

** GenScript Biotech jumps as much as 7.2% to HK$10.98, highest since Dec. 11, 2024

** Stock set for biggest one-day pct rise since Oct. 22, 2024 and is on course for sixth consecutive session of gains

** Co's associate Legend Biotech announces its drug CARVYKTI, used to treat cancer of the bone marrow, brought in ~$334 mln in net trade sales in quarter ended Dec. 31, 2024, up from year-ago $159 mln

** GenScript fell 50.5% last year

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10